OHBs, Half-Year

OHB's Half-Year Report Lands With a Thud — But the Balance Sheet Tells a Different Story

Published on 08/06/2026 at 19:12 | Redaktion boerse-global.de

OHB SE posts 31% EBITDA growth and record orders, but shares slide 6% on profit-taking after a 105% YTD rally.

OHB SE Stock Dips 6% Despite Strong H1 Results and Record Order Book
OHB's Half-Year Report Lands With a Thud — But the Balance Sheet Tells a Different Story Illustration mit AI erstellt übermittelt durch boerse-global.de

The arithmetic of OHB SE's Thursday morning looks almost perverse on its face. The Bremen-based space and defence contractor posted a 31 percent jump in adjusted EBITDA to EUR 60.4 million, lifted total output 11 percent to EUR 627.9 million, and confirmed its full-year guidance without a hint of caution. The stock's response? A 6.25 percent slide to EUR 239.00, extending a pullback that has now carved roughly 65 percent off the shares since they peaked at EUR 688.00 in May.

The apparent contradiction dissolves once the recent run-up is factored in. OHB shares remain up 105.13 percent since the start of January, and Thursday's dip — one source puts it at 6.64 percent, another at 6.25 percent — looks less like a verdict on the operating performance than a bout of profit-taking after a furious rally. The market, in other words, was not pricing the past. It was pricing expectations, and those had climbed steeply.

A Balance Sheet Rebuilt for the Next Phase

Behind the headline numbers sits a more consequential story: OHB has fundamentally reshaped its capital structure in the space of a few weeks. The June capital increase, which raised up to EUR 510.7 million through the placement of 1,605,388 new shares at EUR 300 apiece, lifted the equity ratio from 27.5 percent at the end of 2025 to 43.3 percent by mid-year. The fresh funds are earmarked for Rocket Factory Augsburg and technology acquisitions, giving management the financial runway to execute its growth plans without near-term refinancing pressure.

The mechanics of the raise deserve attention. KKR, through its vehicle Orchid Lux HoldCo, waived its subscription rights and simultaneously placed roughly 4.5 percent of its existing stake with institutional investors — a move that widened the free float and reduced the company's dependence on a single anchor shareholder. By early July, the transaction was complete, with share capital standing at EUR 20,827,928.00. The dilution that accompanied the raise is a live concern for some investors, particularly if further rounds are needed to fund Rocket Factory Augsburg or additional acquisitions down the line.

Should investors sell immediately? Or is it worth buying OHB SE?

Analysts Line Up — With a Range of Conviction

The sell-side response to OHB's trajectory has been broadly constructive, though the dispersion in targets reveals genuine disagreement about valuation. Rothschild & Co Redburn initiated coverage with a "Buy" and a EUR 360 target, while Berenberg and Jefferies launched with buy recommendations and targets between EUR 280 and EUR 358. Goldman Sachs sits at the cautious end with a "Neutral" rating and a EUR 250 target — still above the current price, but signalling that not every observer is prepared to extrapolate the current momentum indefinitely.

The operative backdrop supports the optimists. The order book reached a record EUR 3.304 billion as of June 30, up from EUR 3.067 billion a year earlier, with the Space Systems segment accounting for EUR 2.566 billion. Late July brought two further catalysts: OHB Italia secured the prime contract from the Italian space agency ASI for the "PRISMA Second Generation" hyperspectral Earth observation mission, running through the end of 2031, and OHB welcomed the defence ministry's plans to expand national launch capacity for small satellites — an initiative involving its European Spaceport Company subsidiary.

The Strategic Bet: Defence Meets Space

The longer-term narrative is about positioning, not quarterly numbers. Since January, OHB has been in advanced talks with Rheinmetall over a potential partnership on satellite-based reconnaissance systems for the Bundeswehr — a field gaining urgency amid Europe's rearmament debate. The management's stated ambition, articulated at a Capital Market Day, is to become the "European Space Champion," with investments in serial production capacity to match. The company is deliberately positioning itself at the intersection of space technology and defence, betting that European structural demand will reward that bet over time.

What Happens Next

Technically, the stock is hovering just below its 200-day moving average at EUR 246.94, with the current price of EUR 239.00 sitting underneath. Whether that level holds as support or gives way will likely determine the medium-term trend direction. The distance to the record high is already substantial, and a sustained break below the 200-day line could extend the consolidation phase.

OHB SE at a turning point? This analysis reveals what investors need to know now.

The near-term calendar offers markers for investors. The Berenberg & Goldman Sachs German Corporate Conference in September, the nine-month report in November, and a slot at the German Equity Forum will all provide opportunities for management to make the case that operational strength and share price performance will eventually converge. Progress on the Rheinmetall talks and continued advancement at Rocket Factory Augsburg — whose financing the capital raise was designed to secure — will be the key items to watch.

For now, OHB sits in an uncomfortable but not unfamiliar position: a company with record orders, a fortified balance sheet, and a clear strategic direction, whose shares are being traded on sentiment rather than fundamentals. The next few weeks will indicate whether the market's patience matches the management's ambition.

Ad

OHB SE Stock: New Analysis - 6 August

Fresh OHB SE information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated OHB SE analysis...

Disclaimer...

en | DE0005936124 | OHBS | boerse | 69923685 |